Big $7.2 billion cannabinoid drug acquisition puts Bay Area drug makers in competition

The acquisition, expected to close in the second quarter, could be a watershed moment for cannabinoid drugs.

Source: bizjournals.com Health Care:Biotechnology headlines - February 3, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news